Cookie Policy

By continuing to browse our site, you agree to our use of cookies.

I understand



LaserLeap developed a transdermal drug delivery technology that provides a painless, safe and effective method to administer medicines and cosmetics through the skin.

ISTART I fund exited LaserLeap on a trade sale with its management team, in January 2018.